Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|February 7, 2025
Chronic fatigue and headache in post-COVID-19 syndrome: a radiological and clinical evaluationGonçalo G Almeida, Saide Alkan, Robert Hoepner, et al.
Multiple Sclerosis and Related Disorders|October 18, 2025
Characterizing post-COVID-19 syndrome in multiple sclerosis: Vaccine status, infection burden, and therapy categories as predictorsDeepak Sharma, Christian P Kamm, Robert Hoepner, et al.
Therapeutische Umschau. Revue Therapeutique|May 18, 2022
[Primary CNS Vasculitis - An Overview]Helly Hammer, Nicole Kamber, Christoph Friedli, et al.
Journal of Translational Autoimmunity|December 1, 2022
Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysisMirjam Kolev, Stefan Diem, Lara Diem, et al.
Therapeutic Advances in Neurological Disorders|May 21, 2019
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient ageMyriam Briner, Maud Bagnoud, Andrei Miclea, et al.
Therapeutic Advances in Neurological Disorders|January 15, 2021
Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational studyLara Diem, Maxine Bürge, Alexander Leichtle, et al.
Therapeutic Advances in Neurological Disorders|August 5, 2021
Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective studyPanagiotis Chaloulos-Iakovidis, Franca Wagner, Lea Weber, et al.
CNS Neuroscience & Therapeutics|December 8, 2022
Multiple sclerosis as a model to investigate SARS-CoV-2 effect on brain atrophyMichael Rebsamen, Christoph Friedli, Piotr Radojewski, et al.
Cureus|August 18, 2025
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective StudyLara Diem, Simona Daepp, Vincenzo P Introcaso, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 16, 2022
Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patientsChristoph Friedli, Franca Wagner, Helly Noemi Hammer, et al.
Pageof 3